Living Cell Technologies Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Living Cell Technologies Ltd with three other
companies in this sector in AUSTRALIA :
Invex Therapeutics Ltd
sales of 158,785.00 Australian Dollars [US$115,228.69 ]
of which 100%
was Clinical Drug Development),
(418,168.00 Australian Dollars [US$303,460.34 ]
of which 75%
was Cancer Immunotherapy), and
Suda Pharmaceuticals Ltd
(263,889.00 Australian Dollars [US$191,501.61 ]
Living Cell Technologies Ltd reported sales of A$268,184.00 (US$194.62 thousand)
June of 2021.
decrease of 51.6%
versus 2020, when the company's sales were A$553,692.00 .